Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

Gilead lead NASH drug flunks phase 3 test

Analysts suspect the setback could prompt Gilead to license other candidates

- PMLiVE

Industry concerned about ‘rushed’ Brexit withdrawal legislation

The Patents Amendment could weaken the UK’s IP framework, warns biopharma

- PMLiVE

The Real & The Honestly Fake

In the age of the Instagram filter and the selfie, there appears to be no place in healthcare creative for false perceptions. You’re either REAL, or you’re HONESTLY FAKE.

Page & Page Health

- PMLiVE

Grey Wolf secures £10m Series A to ‘illuminate’ tumour cells

The tech could offer a new treatment paradigm

- PMLiVE

Finch’s microbiota drug for C. diff gets FDA breakthrough status

Boost for firm as it races rivals in microbiome space

EU flag

Europe’s medicines tracking system goes live

Covers 140,000 pharmacies in 28 countries

- PMLiVE

UniQure edges closer to haemophilia B gene therapy OK

The candidate could free patients from regulator injections of FIX products

- PMLiVE

Changing healthcare communications

Replacing anxiety with confidence, mediocrity with purpose

How to add some magic to your pharma exhibition stand design

How to add some magic to your pharma exhibition stand design

Buying the right exhibition stand system and making it look good isn’t enough to make sure your pharmaceutical tradeshow presence is maximised. You’ll also need to add some magic.

Apex Events and Exhibitions

- PMLiVE

Alector kicks off next wave of biotech IPOs

US biotech raising money again

- PMLiVE

No deal Brexit would see UK miss out on ‘safest medicines system in the world’

Health leaders say it would be 'a travesty'

- PMLiVE

Trial dents confidence in Sangamo’s gene-editing tech

Company proposing switch to next-gen version

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links